1. Home
  2. ABP

as 04-01-2025 3:30pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Founded: 2004 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 26.5M IPO Year: N/A
Target Price: $4.00 AVG Volume (30 days): 52.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.82 EPS Growth: N/A
52 Week Low/High: $0.41 - $13.00 Next Earning Date: 05-18-2025
Revenue: $230,000 Revenue Growth: -89.07%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: